OS Therapies IncorporatedOSTXNYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+36.2%
5Y CAGR+573.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+36.2%/yr
Annual compound
5Y CAGR
+573.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
13804.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.31M | +192.9% |
| 2024 | $2.84M | -11.8% |
| 2023 | $3.22M | -2.3% |
| 2022 | $3.29M | +51.4% |
| 2021 | $2.17M | +361193.1% |
| 2020 | $601.78 | - |